Marion Enie, BS, Certificate Industrial Chemistry; Business Management, CMPP, Consulting Solutions Business LeadLinkedIn
Marion has been with Envision since 2006, assuming increasing responsibilities and leading teams across multiple accounts and therapeutic areas…
Marion leads Consulting Solutions where she leverages her broad expertise specializing in evidence-based strategic communication planning including therapeutic landscape, needs assessment and scientific platform development throughout all stages of the product lifecycle.
Marion began her career as a clinical medical technologist. Through an intense interest in product development, Marion accepted an appointment at Indiana University as Manager of Technology Transfer where she acted as the liaison between the University and industry to help commercialize the University’s intellectual property. Rounding out her experience, Marion spent seven years at Eli Lilly, where she led patient and professional programs in diabetes and mental health.
Marion is active in the International Society of Medical Publications Professionals (ISMPP) and has served on the Annual Meeting Workshop Committee from 2009–2011.
Marion’s broad healthcare experience from her more than 25-year career spanning clinical, academic, industry, and agency perspectives provides a an excellent springboard to solve strategic challenges in communication planning.
Jeanette Cook, BSc (Hons), PhD, CMPP, Consultancy Solutions Scientific LeadLinkedIn
Jeanette specializes in providing evidence-based, scientifically robust, strategic-planning support across country and global accounts – working across a diverse range of therapy areas, with products at various stages of development…
For the past few years Jeanette has also been involved in providing consultation services to the pharma industry on publication best practices and implementation; including SOP development and refinement, training materials, and internal audits.
After completing her PhD and post-doctoral research in neuroscience, Jeanette worked as a research scientist at a top 10 pharmaceutical company investigating brain disorders, before embarking on a career in medical communications. Her scientific training sparked a keen interest in ethical standards and industry best practices which makes Jeanette ideally placed to co-lead Envision Pharma’s Consultancy Solutions team. Jeanette regularly works with clients to develop robust, effective best practices. Jeanette is also an active member of the International Society for Medical Publication Professionals (ISMPP) and is involved in the development of the new Good Publication Practice guidelines (GPP3).
Jeanette has over 20 years of experience in the pharmaceutical and healthcare industry spanning academia, industry, and agency giving her a well-rounded perspective for developing strategic communication solutions and advising on industry leading best practices.
Joseph Kohles, PhD, Group Director, Scientific and Medical AffairsLinkedIn
Joe’s role at Envision is leading the medical strategy team...
Joseph Kohles, PhD, is a dynamic leader with more than 20 years of research and industry-side pharmaceutical experience, both in medical marketing and clinical research. In addition to a broad range of experience across multiple therapeutic areas, Dr. Kohles has written and published extensively in areas such as basic research, preclinical, clinical, health outcomes, and pharmacoeconomic analysis.
In 2009, Joe founded the Alligent Group, which evolved rapidly into a mid-size agency specializing in medical strategy, but also offering a considerable level of consulting in commercial strategy, before being acquired by Envision Pharma Group in August 2015.
Prior to founding Alligent, Joe’s most recent role was in leading the oncology medical affairs team for a large Fortune 100 pharmaceutical company in the US. In this capacity, Dr. Kohles guided the overall medical strategy and led the team in execution of clinical trials, outcomes analyses, publications plans, and overall commercial support.
– 20 years’ research and industry-side pharma experience: medical marketing and clinical research.
– Written and published more than 20 peer-reviewed manuscripts and over 60 abstracts and posters.
– PhD in Chemistry from Seton Hall University, NJ.
David Thompson, Group Director, Business StrategyLinkedIn
David’s role at Envision is to oversee the build out of medical strategy and communications work across the entire company, leveraging our science, technology and compliance leadership...
David is a highly experienced senior executive in the medical communications industry, spending 17 years in medical communications in various leadership positions in Europe and in the US, before joining Alligent Group. In 2002, David moved to the US to set up Gardiner-Caldwell’s US division, which was hugely successful, focusing heavily on oncology launch programs with major Pharma clients. The division expanded to incorporate 4 regional offices and multiple agency brands and David joined the KnowledgePoint360 Group holding company operational board of directors (now Ashfield). In late 2013, David joined Dr. Joe Kohles at Alligent Group as Partner and Managing Director. Alligent Group had evolved rapidly into a mid-size agency specializing in medical strategy, but also offering a considerable level of consulting in commercial strategy, before being acquired by Envision Pharma Group in August, 2015.
– David spent his early career with Pricewaterhouse-Coopers, and then worked in education before entering the medical communications field.
– 17 years’ experience in medical communications and leadership across Europe and the US.
– David earned a Bachelor of Arts degree in Economics from the University of Newcastle-upon-Tyne, UK, followed by postgraduate work in Education at the University of Manchester, also in the UK.